BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/7/2021 8:39:46 AM | Browse: 697 | Download: 1501
Publication Name World Journal of Clinical Cases
Manuscript ID 63267
Country Croatia
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Minireviews
Article Title Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
Manuscript Source Invited Manuscript
All Author List Danko Mikulic and Anna Mrzljak
ORCID
Author(s) ORCID Number
Danko Mikulic http://orcid.org/0000-0001-8103-6045
Anna Mrzljak http://orcid.org/0000-0001-6270-2305
Funding Agency and Grant Number
Corresponding Author Danko Mikulic, FEBS, MD, PhD, Surgeon, Department of Surgery, University Hospital Merkur, Zajceva 19, Zagreb 10000, Croatia. danko.mikulic@zg.t-com.hr
Key Words Pancreatic adenocarcinoma; Borderline resectable; Neoadjuvant therapy; Venous resection; Arterial resection; Vascular reconstruction
Core Tip Curative treatment of pancreatic ductal adenocarcinoma is only possible after margin negative surgical resection. Borderline resectable pancreatic cancer is characterized by vascular tumor involvement and the need to perform vascular resection to achieve radical resection. This report reviewed the characteristics of borderline resectable pancreatic cancer and the current treatment perspectives, including aggressive surgical approaches in the era of neoadjuvant therapy.
Publish Date 2021-07-07 08:39
Citation Mikulic D, Mrzljak A. Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy. World J Clin Cases 2021; 9(20): 5398-5407
URL https://www.wjgnet.com/2307-8960/full/v9/i20/5398.htm
DOI https://dx.doi.org/10.12998/wjcc.v9.i20.5398
Full Article (PDF) WJCC-9-5398.pdf
Full Article (Word) WJCC-9-5398.docx